Drug Shortage Report for APO-ELETRIPTAN

Last updated on 2021-11-19 History
Report ID 123558
Drug Identification Number 02386062
Brand name APO-ELETRIPTAN
Common or Proper name ELETRIPTAN
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) ELETRIPTAN
Strength(s) 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 6 BLS
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-31
Estimated end date 2021-11-19
Actual end date 2021-11-18
Shortage status Resolved
Updated date 2021-11-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2021-11-19 French Compare
v24 2021-11-19 English Compare
v23 2021-11-08 French Compare
v22 2021-11-08 English Compare
v21 2021-11-02 French Compare
v20 2021-11-02 English Compare
v19 2021-10-15 French Compare
v18 2021-10-15 English Compare
v17 2021-09-27 French Compare
v16 2021-09-27 English Compare
v15 2021-09-15 French Compare
v14 2021-09-15 English Compare
v13 2021-07-29 French Compare
v12 2021-07-29 English Compare
v11 2021-07-29 English Compare
v10 2021-05-07 French Compare
v9 2021-05-07 English Compare
v8 2020-12-11 French Compare
v7 2020-12-11 English Compare
v6 2020-11-06 French Compare

Showing 1 to 20 of 25